Pulmonx Corporation LUNG Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $88.55M+1.2% | $90.5M+8.0% | $91.66M+15.6% | $90.55M+18.2% | $87.47M+19.8% | ||
| $21.7M-6.5% | $23.36M+7.2% | $24.48M+19.4% | $24.39M+23.4% | $23.21M+23.8% | ||
| $66.84M+4.0% | $67.14M+8.3% | $67.19M+14.2% | $66.16M+16.5% | $64.27M+18.5% | ||
| 75.5%+2.0pp | 74.2%+0.2pp | 73.3%-0.9pp | 73.1%-1.1pp | 73.5%-0.8pp | ||
| $19.63M+8.4% | $19.49M+10.9% | $18.91M+8.3% | $17.81M-0.7% | $18.12M+0.4% | ||
| $99.26M-4.4% | $101.31M-0.8% | $105.46M+5.9% | $105.27M+7.3% | $103.88M+7.9% | ||
| $118.9M-2.5% | $120.8M+0.9% | $124.37M+6.3% | $123.08M+6.0% | $122M+6.7% | ||
| $118.9M-2.5% | $120.8M+0.9% | $124.37M+6.3% | $123.08M+6.0% | $122M+6.7% | ||
| -$52.06M+9.8% | -$53.66M+7.0% | -$57.18M+1.8% | -$56.91M+3.9% | -$57.73M+3.9% | ||
| -58.8%+7.2pp | -59.3%+9.6pp | -62.4%+11.0pp | -62.9%+14.5pp | -66%+16.3pp | ||
| $3.35M-1.6% | $3.16M-10.0% | $3.23M-9.6% | $3.31M-7.3% | $3.41M-3.9% | ||
| $2.14M-52.3% | $2.65M-47.6% | $3.24M-41.6% | $3.9M-32.5% | $4.48M-23.8% | ||
| $719K+8,888% | $809K+216% | $886K+598% | -$73K+69.5% | $8K+102% | ||
| -$52.57M+7.2% | -$53.38M+4.5% | -$56.28M+0.2% | -$56.4M+1.6% | -$56.64M+2.5% | ||
| $640K+42.5% | $626K+25.2% | $478K-32.7% | $542K-6.1% | $449K-29.1% | ||
| -$53.21M+6.8% | -$54M+4.2% | -$56.75M+0.6% | -$56.94M+1.6% | -$57.09M+2.8% | ||
| -60.1%+5.2pp | -59.7%+7.6pp | -61.9%+10.1pp | -62.9%+12.7pp | -65.3%+15.2pp | ||
| -$1.30+9.7% | -$1.33+7.6% | -$1.41+4.1% | -$1.43+4.7% | -$1.44+6.5% | ||
| -$1.30+9.7% | -$1.33+7.6% | -$1.41+4.1% | -$1.43+4.7% | -$1.44+6.5% | ||
| 164M+4.2% | 162M+3.9% | 160.4M+3.6% | 158.8M+3.3% | 157.3M+3.1% | ||
| 164M+4.2% | 162M+3.9% | 160.4M+3.6% | 158.8M+3.3% | 157.3M+3.1% | ||
| -$53.24M+6.4% | -$53.76M+5.6% | -$57.05M-0.9% | -$56.28M+2.7% | -$56.85M+3.0% | ||
| $719K+8,888% | $809K+216% | $886K+598% | -$73K+69.5% | $8K+102% | ||
| $88.55M+1.2% | $90.5M+8.0% | $91.66M+15.6% | $90.55M+18.2% | $87.47M+19.8% | ||
| -$52.06M+9.8% | -$53.66M+7.0% | -$57.18M+1.8% | -$56.91M+3.9% | -$57.73M+3.9% | ||
| -$51.06M+9.4% | -$52.61M+6.4% | -$56.06M+1.2% | -$55.67M+3.6% | -$56.38M+3.7% | ||
| -$51.06M+9.4% | -$52.61M+6.4% | -$56.06M+1.2% | -$55.67M+3.6% | -$56.38M+3.7% | ||
| -57.7%+6.8pp | -58.1%+9.0pp | -61.2%+10.4pp | -61.5%+13.9pp | -64.5%+15.7pp | ||
| -$52.06M+9.8% | -$53.66M+7.0% | -$57.18M+1.8% | -$56.91M+3.9% | -$57.73M+3.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pulmonx Corporation's revenue?
- Pulmonx Corporation (LUNG) generated $88.5M in revenue over the trailing twelve months, up 1.2% year over year.
- Is Pulmonx Corporation profitable?
- Pulmonx Corporation is not currently profitable: it reported a net loss of $53.2M over the trailing twelve months, a -60.1% net margin.
- What are Pulmonx Corporation's profit margins?
- Gross margin is 75.5% and operating margin is -58.8%, with a -60.1% net margin.
- What is Pulmonx Corporation's earnings per share?
- Pulmonx Corporation's diluted EPS over the trailing twelve months is $-1.30.
- Where does Pulmonx Corporation's income statement data come from?
- Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
